2012, Number 2
Rev Cubana Hematol Inmunol Hemoter 2012; 28 (2)
Jaime-Fagundo JC, Arencibia-Núñez A, Romero-González A, Anoceto-Martínez A, Pavón-Morán V
PDF size: 51.67 Kb.
ABSTRACTExtravasation is one of the most serious complications during intravenous administration of cytostatics. In this paper we describe how an unintentional output of a cytostatic drug to the perivascular or subcutaneous space can occur during its administration, resulting from diverse factors. Its incidence is 0,1 to 6 %, according to different reports. There are dissimilar protocols for treatment and all agree that applying physical and pharmacological measures is the most important, as soon as each case require.